Ratings by Jones Trading (Justin Walsh)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/18/2026 | VolitionRX | VNRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2026 | Neuroone Medical Technologies | NMTC | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2026 | Alto Neuroscience | ANRO | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2026 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2026 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2026 | TriSalus Life Sciences, Inc. | TLSI | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Neuroone Medical Technologies | NMTC | New Coverage | Buy (N/A) |
0.67 (3.25) |
385.07% | Details | |
| 2/26/2026 | Lantheus Holdings | LNTH | Downgrade | Hold (Buy) |
75.72 (106.20) |
40.25% | Details | |
| 2/19/2026 | Beyond Air | XAIR | Maintain | Buy (N/A) |
|
Details | ||
| 1/30/2026 | RenovoRx Inc. | RNXT | New Coverage | Buy (N/A) |
0.90 (0.91) |
1.11% | Details | |
| 12/23/2025 | atai Life Sciences N.V | ATAI | New Coverage | Buy (N/A) |
4.30 (4.05) |
-5.81% | Details | |
| 12/23/2025 | MindMed | MNMD | New Coverage | Buy (N/A) |
13.30 (15.02) |
12.93% | Details | |
| 11/11/2025 | Beyond Air | XAIR | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2025 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Buy (N/A) |
42.00 (303.39) |
622.36% | Details | |
| 8/7/2025 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Y-mAbs Therapeutics | YMAB | Downgrade | Hold (Buy) |
4.19 (8.61) |
105.49% | Details | |
| 7/22/2025 | Beyond Air | XAIR | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2025 | Theratechnologies Inc. | THTX | Maintain | Hold (N/A) |
|
Details | ||
| 7/3/2025 | Theratechnologies Inc. | THTX | Downgrade | Hold (Buy) |
2.36 (3.39) |
43.64% | Details | |
| 6/10/2025 | VolitionRX | VNRX | New Coverage | Buy (N/A) |
0.55 (1.34) |
143.64% | Details | |
| 6/3/2025 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2025 | BioLineRx | BLRX | Upgrade | Buy (Hold) |
3.79 (3.24) |
-14.51% | Details | |
| 5/28/2025 | BioLineRx | BLRX | Maintain | Hold (N/A) |
|
Details | ||
| 5/22/2025 | Radiopharm Theranostics | RADX | New Coverage | Buy (N/A) |
4.18 (4.31) |
3.11% | Details | |
| 5/8/2025 | Vor Biopharma, Inc. | VOR | Downgrade | Hold (Buy) |
0.54 (14.94) |
2666.67% | Details | |
| 4/11/2025 | Theratechnologies Inc. | THTX | Upgrade | Buy (Hold) |
1.33 (2.36) |
77.44% | Details | |
| 4/2/2025 | Monopar Therapeutics | MNPR | Downgrade | Hold (Buy) |
33.43 (100.96) |
202% | Details | |
| 4/2/2025 | BioLineRx | BLRX | Downgrade | Hold (Buy) |
2.96 (3.79) |
28.04% | Details | |
| 3/13/2025 | Rapport Therapeutics | RAPP | New Coverage | Buy (N/A) |
8.96 (38.19) |
326.23% | Details | |
| 3/11/2025 | Serina THerapeutics | SER | New Coverage | Buy (N/A) |
4.80 (1.89) |
-60.63% | Details | |
| 3/5/2025 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2025 | Beyond Air | XAIR | New Coverage | Buy (N/A) |
0.38 (0.41) |
7.89% | Details | |
| 12/16/2024 | Alto Neuroscience | ANRO | New Coverage | Buy (N/A) |
3.83 (22.93) |
498.69% | Details | |
| 11/19/2024 | Monopar Therapeutics | MNPR | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2024 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2024 | Rapport Therapeutics | RAPP | New Coverage | Buy (N/A) |
29.23 (38.19) |
30.65% | Details | |
| 10/10/2024 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2024 | Monopar Therapeutics | MNPR | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | BioLineRx | BLRX | New Coverage | Buy (N/A) |
0.65 (2.96) |
355.38% | Details | |
| 8/27/2024 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2024 | TriSalus Life Sciences, Inc. | TLSI | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2024 | Monopar Therapeutics | MNPR | New Coverage | Buy (N/A) |
0.64 (33.43) |
5123.44% | Details | |
| 7/18/2024 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2024 | Y-mAbs Therapeutics | YMAB | New Coverage | Buy (N/A) |
11.55 (8.61) |
-25.45% | Details | |
| 6/18/2024 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2024 | Mainz Biomed B.V. | MYNZ | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2024 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | TriSalus Life Sciences, Inc. | TLSI | New Coverage | Buy (N/A) |
9.66 (4.20) |
-56.52% | Details | |
| 4/16/2024 | Achieve Life Sciences | ACHV | New Coverage | Buy (N/A) |
4.45 (5.10) |
14.61% | Details | |
| 4/4/2024 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2024 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Fusion Pharmaceuticals | FUSN | Downgrade | Hold (Buy) |
10.64 (21.55) |
102.54% | Details | |
| 12/20/2023 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2023 | Perspective Therapeutics Inc | CATX | New Coverage | Buy (N/A) |
0.23 (3.05) |
1226.09% | Details | |
| 10/30/2023 | Theratechnologies Inc. | THTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2023 | POINT Biopharma Global Inc. | PNT | Downgrade | Hold (Buy) |
6.68 (12.50) |
87.13% | Details | |
| 5/16/2023 | Vor Biopharma, Inc. | VOR | New Coverage | Buy (N/A) |
4.32 (0.54) |
-87.5% | Details | |
| 3/22/2023 | TFF Parmaceuticals | TFFP | New Coverage | Buy (N/A) |
0.74 (0.07) |
-90.54% | Details | |
| 2/10/2023 | Mainz Biomed B.V. | MYNZ | New Coverage | Buy (N/A) |
6.60 (0.84) |
-87.27% | Details | |
| 1/29/0202 | Rein Therapeutics | RNTX | New Coverage | Buy (N/A) |
1.52 (0.90) |
-40.79% | Details |
